Notizie Aprea Therapeutics - APRE

Ultime notizie

Data	Ora	Fonte	Titolo
14/5/2024	14:40	EDGAR2	Form 8-K - Current report
14/5/2024	14:35	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/2/2024	23:01	EDGAR2	Form 8-K - Current report
05/2/2024	06:15	EDGAR2	Form EFFECT - Notice of Effectiveness
02/2/2024	22:26	EDGAR2	Form 8-K - Current report
26/1/2024	13:13	EDGAR2	Form 8-K - Current report
26/1/2024	12:03	EDGAR2	Form S-3 - Registration statement under Securities Act of..
04/1/2024	22:16	EDGAR2	Form 8-K - Current report
09/11/2023	22:20	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
09/11/2023	22:15	EDGAR2	Form 8-K - Current report
09/11/2023	22:10	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
16/10/2023	23:29	EDGAR2	Form 8-K - Current report
13/10/2023	13:31	EDGAR2	Form 8-K - Current report
11/9/2023	14:30	EDGAR2	Form 8-K - Current report
25/8/2023	03:52	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
25/8/2023	03:50	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
25/8/2023	03:48	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
24/8/2023	14:00	EDGAR2	Form 8-K - Current report
10/8/2023	13:39	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/2023	13:36	EDGAR2	Form 8-K - Current report
11/7/2023	13:30	EDGAR2	Form DEF 14A - Other definitive proxy statements
05/7/2023	22:01	EDGAR2	Form 8-K - Current report
14/6/2023	14:00	GLOBE	Aprea Therapeutics to Present at Maxim Virtual Healthcare..
30/5/2023	14:30	GLOBE	Aprea Therapeutics to Present at BIO International..

Apertura:	Min:	Max:
Chiusura: 5,19